Pepfar

Rediff.com » News » Pepfar

News for Pepfar

Business

Indian pharma eyes US gains as $63.7 bn patent cliff nears

The Indian pharmaceutical industry is likely to benefit from a major wave of patent expiries in the US, as small-molecule drugs worth $63.7 billion are expected to go off-patent between 2025–29,......

'Made in India' dominates US AIDS scheme

Indian drug companies have cornered an overwhelming majority of drug approvals under the US President's Emergency Plan for AIDS Relief (Pepfar). Out of the 100 approvals by the US drug regulator......

Ranbaxy files three anti-Retoviral patents

Ranbaxy Laboratories Ltd announced on Monday that the company has so far made three filings of its anti-Retrovirals to the USFDA (Food & Drug Administration) for its approval under the expedited......

America should listen harder to India

Narendra Modi's bold leadership, at the WTO and in the neighbourhood, says, loudly: 'Take India seriously’, points out Ron Somers. Savvy investors should discount naysayers who have blasted......

Top Coverage News

World Test Championship 2023

India held the top position in the ICC Men's Test Team Rankings while Australia secured the...

Manipur's Tragedy

Here are news, updates and coverage from violence hit Manipur.

IPL 2023

Complete coverage of IPL 2023

Sri Lanka's Tour of India 2023

Complete Coverage of Indian cricket team's encounter with Sri Lanka during 3rd Jan - 15th Jan 2023.

GUJARAT, HIMACHAL GO TO POLLS

The Bharatiya Janata Party was on Thursday poised for a landslide victory in Gujarat to retain...

Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Rediffmail for WorkBook a domainRediffmailMoneyOnline ShoppingVideos